Neurology

Symptoms, Diagnostic Tests & Avoiding Misdiagnosis

At a Glance

Familial Alzheimer-like prion disease can mimic early-onset Alzheimer’s on symptoms, biomarkers, and PET scans. PRNP sequencing is central to finding an inherited cause, while a negative RT-QuIC or MRI does not reliably rule out every genetic prion variant.

Diagnosing familial Alzheimer-like prion disease is notoriously difficult because it often “borrows” the symptoms and test results typically associated with Alzheimer’s disease. Many families spend years being told their loved one has Early-Onset Alzheimer’s before the true genetic cause is discovered ^[1]^[2]. Understanding the unique symptoms and the limitations of standard tests can help you ensure your loved one receives the correct evaluation.

Symptoms Beyond Memory Loss

While memory loss is often the first sign, genetic prion diseases frequently cause “clues” that are not typical for Alzheimer’s. Depending on the specific mutation, you may see:

Gastrointestinal and Nerve Issues: In the Y157X mutation, patients have been reported to experience chronic nausea, vomiting, or nerve pain (peripheral neuropathy) alongside cognitive decline ^[1].
Movement and Balance Problems: Many variants, such as T107I or 5-OPRI, eventually cause ataxia (clumsiness or lack of coordination), tremors, or muscle stiffness (parkinsonism) ^[3]^[4].
Frontal-Lobe Changes: The 5-OPRI variant often mimics Frontotemporal Dementia, causing early changes in personality, judgment, or social behavior ^[4]^[5].
Myoclonus: These are sudden, brief “shocks” or muscle jerks that are much more common in prion diseases than in early Alzheimer’s ^[4].

Why Standard Tests Can Be Misleading

A major reason for misdiagnosis is that these diseases can trigger the same “alarm bells” in the brain as Alzheimer’s, leading to confusing lab results:

Misleading Blood/Spinal Fluid Markers: Mutations like Y157X can cause an increase in p-tau181, a biomarker doctors often use to support Alzheimer’s ^[1]. While other markers like NfL (Neurofilament Light) are high in prion disease, they are nonspecific and only show that brain cells are being damaged ^[6]^[7].
PET Scan Confusion: Brain scans that measure sugar use (FDG-PET) may show patterns of low activity in the parietal and temporal lobes—a hallmark “signature” of Alzheimer’s—even when the actual cause is a prion mutation ^[8]^[9].
Amyloid Paradox: While Amyloid-PET scans (which look for Alzheimer’s plaques) can reduce the likelihood of amyloid pathology when negative, results vary by assay and do not establish a prion diagnosis ^[8]^[1]. Mixed pathology remains possible.

Tests Your Specialist May Consider

Standard tests are often not enough to confirm or rule out a genetic prion disease. Your specialist may select from the following tools:

PRNP Genetic Sequencing: This is essential when an inherited disorder is suspected ^[10]. It identifies the exact variant and your loved one’s codon-129 status ^[11]^[4]. A pathogenic result is highly important, but a variant of uncertain significance (VUS) needs specialist interpretation.
CSF RT-QuIC: This is a highly specific “seeding assay” used to find abnormal prions in spinal fluid. However, its sensitivity is low for certain genetic variants like GSS and some OPRI mutations ^[10]^[12]. A negative RT-QuIC test does not mean your loved one is free of prion disease ^[12]^[13].
MRI (DWI): Special MRI settings (Diffusion-Weighted Imaging) can sometimes show “cortical ribboning” (bright spots on the brain’s surface) ^[14]. However, this is not pathognomonic, and in slowly progressive genetic forms, these signs can be very subtle or absent ^[15]^[2].

Understanding Lab Results

If you are reviewing your loved one’s medical records, the following tests might be considered by a specialist, though the absence of one does not mean the evaluation was incomplete:

Test Category	What to Look For	What It Can Establish
Genetic Test	PRNP Gene Sequencing	Essential for finding the inherited variant; requires clinical interpretation.
Spinal Fluid	RT-QuIC (Prion Seeding)	Specific for prions, but a negative result isn’t definitive for genetic forms.
Spinal Fluid	14-3-3 and Total Tau	Indicate rapid brain cell damage, not specific to prion disease ^[10].
Brain Imaging	MRI with DWI/ADC	Looks for specific “bright” patterns of damage, but can be negative ^[14].
Brain Imaging	Amyloid-PET	A negative scan reduces the likelihood of Alzheimer’s but doesn’t prove prion ^[8].
Blood Test	NfL (Neurofilament Light)	A nonspecific marker that is not universally validated for routine individual monitoring ^[16].

Common questions in this guide

Why can familial Alzheimer-like prion disease be mistaken for Alzheimer’s disease?

It can cause memory loss and cognitive decline, and an Alzheimer’s-associated marker called p-tau181 or an FDG-PET scan may also look typical for Alzheimer’s. Movement problems, myoclonus (brief muscle jerks), nerve or stomach symptoms, unusual behavior changes, or a family history may provide additional clues.

What genetic test is used for familial prion disease?

PRNP gene sequencing looks for the inherited change linked to the disease and can identify codon-129 status, which may help specialists interpret the result. A disease-causing variant is important evidence, while a variant of uncertain significance needs expert review and does not by itself confirm the diagnosis.

Can a negative RT-QuIC test rule out familial prion disease?

No. The spinal-fluid RT-QuIC test is highly specific when it detects abnormal prion seeding, but it can be less sensitive in some genetic forms, including GSS and certain OPRI mutations, so a negative result does not exclude the disease.

What does a high p-tau181 result mean in suspected genetic prion disease?

A high p-tau181 level can occur in some genetic prion diseases, including Y157X, so it does not prove that Alzheimer’s disease is the cause. Other markers such as NfL, 14-3-3, and total tau can reflect brain-cell injury but are not specific enough to diagnose a prion disease on their own.

What can an MRI show in familial Alzheimer-like prion disease?

An MRI using diffusion-weighted imaging may show cortical ribboning, or bright areas along the brain’s surface. The finding is not unique to prion disease, and it may be subtle or absent in slowly progressive genetic forms, so a normal or unclear MRI does not settle the diagnosis.

Does a negative amyloid-PET scan confirm prion disease?

No. A negative amyloid-PET scan lowers the likelihood of Alzheimer’s plaque-related disease, but results can vary by testing method and more than one brain disease can occur at the same time. The scan does not establish a prion diagnosis, so genetic and clinical evaluation may still be needed.

Curated prompts to bring to your next appointment.

1.Has my loved one had a PRNP genetic sequencing test, and what were the results for the mutation and codon-129?
2.If the CSF RT-QuIC test was negative, does that definitely rule out this specific genetic variant?
3.Why were some Alzheimer's markers (like p-tau181) elevated if this is a prion disease?
4.Were the MRI scans specifically reviewed for 'cortical ribboning' or signs of prion disease by a specialist?
5.Are the gastrointestinal or nerve symptoms we are seeing related to the PRNP mutation?
6.Should we repeat any tests if the symptoms have changed significantly since the first evaluation?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (16)

1
Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157.
Holm-Mercer L, Mok TH, Sequeira D, et al.
Journal of Alzheimer's disease : JAD 2025; (106(3)):1087-1096 doi:10.1177/13872877251351182.
PMID: 40611688
2
Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review.
Elgenidi A, Shir D, Piura YD, et al.
Journal of neurology 2026; (273(10)).
PMID: 42702666
3
The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer's disease.
Holm-Mercer L, Coysh T, Mok TH, et al.
Journal of neurogenetics 2025; (39(1)):16-22 doi:10.1080/01677063.2024.2440395.
PMID: 39789805
4
Genetic Creutzfeldt-Jakob disease associated with 5-octapeptide repeat insertion in the PRNP gene: case and pedigree report and literature review.
Geng Q, Liu R, Xia J, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(6)).
PMID: 42185544
5
Genetic Creutzfeldt‒Jakob disease with 5-octapeptide repeats presented as frontotemporal dementia.
Hamada S, Takahashi-Iwata I, Satoh K, et al.
Human genome variation 2023; (10(1)):10 doi:10.1038/s41439-023-00237-w.
PMID: 36977684
6
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.
Coysh T, Laban R, Veleva E, et al.
Neurology 2026; (107(3)):e214712 doi:10.1212/WNL.0000000000214712.
PMID: 42441927
7
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
Steinacker P, Blennow K, Halbgebauer S, et al.
Scientific reports 2016; (6()):38737 doi:10.1038/srep38737.
PMID: 27929120
8
Inherited Prion Disease with a 5-octapeptide Repeat Insertion in the PRNP Gene Presenting with Familial Juvenile Dementia.
Nishikawa M, Takeda A, Miyazawa N, et al.
Internal medicine (Tokyo, Japan) 2025; (64(18)):2769-2773 doi:10.2169/internalmedicine.5143-24.
PMID: 40058853
9
The Role of PET Imaging in Patients with Prion Disease: A Literature Review.
Mattoli MV, Giancipoli RG, Cocciolillo F, et al.
Molecular imaging and biology 2024; (26(2)):195-212 doi:10.1007/s11307-024-01895-0.
PMID: 38302686
10
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Schmitz M, Villar-Piqué A, Hermann P, et al.
Brain : a journal of neurology 2022; (145(2)):700-712 doi:10.1093/brain/awab350.
PMID: 35288744
11
Genetic Creutzfeldt-Jakob disease linked to the E200K mutation: a large cohort study.
Appleby BS, Manca M, Piazza MS, et al.
Acta neuropathologica 2026; (151(1)):5 doi:10.1007/s00401-026-02975-x.
PMID: 41528501
12
Diagnosis of prion diseases by RT-QuIC results in improved surveillance.
Rhoads DD, Wrona A, Foutz A, et al.
Neurology 2020; (95(8)):e1017-e1026 doi:10.1212/WNL.0000000000010086.
PMID: 32571851
13
Analysis of 12 Chinese Patients with Proline-to-Leucine Mutation at Codon 102-Associated Gerstmann-Sträussler-Scheinker Disease.
Wang J, Xiao K, Zhou W, et al.
Journal of clinical neurology (Seoul, Korea) 2019; (15(2)):184-190 doi:10.3988/jcn.2019.15.2.184.
PMID: 30877692
14
A Chinese patient of P102L Gerstmann-Sträussler-Scheinker disease contains three other disease-associated mutations in SYNE1.
Wang J, Xiao K, Zhou W, et al.
Prion 2018; (12(2)):150-155 doi:10.1080/19336896.2018.1447733.
PMID: 29509064
15
Clinical Variability in P102L Gerstmann-Sträussler-Scheinker Syndrome.
Tesar A, Matej R, Kukal J, et al.
Annals of neurology 2019; (86(5)):643-652 doi:10.1002/ana.25579.
PMID: 31397917
16
Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
Vallabh SM, Mortberg MA, Allen SW, et al.
Neurology 2024; (103(2)):e209506 doi:10.1212/WNL.0000000000209506.
PMID: 38896810

This page is for informational purposes only and does not constitute medical advice. A neurologist or medical genetics specialist should interpret PRNP, spinal-fluid, MRI, and PET results for your loved one.

Get notified when new evidence is published on Familial Alzheimer-like prion disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents